205 related articles for article (PubMed ID: 27187859)
1. Novel spirothiazamenthane inhibitors of the influenza A M2 proton channel.
Arns S; Balgi AD; Shimizu Y; Pfeifer TA; Kumar N; Shidmoossavee FS; Sun S; Tai SS; Agafitei O; Jaquith JB; Bourque E; Niikura M; Roberge M
Eur J Med Chem; 2016 Sep; 120():64-73. PubMed ID: 27187859
[TBL] [Abstract][Full Text] [Related]
2. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.
Hu Y; Musharrafieh R; Ma C; Zhang J; Smee DF; DeGrado WF; Wang J
Antiviral Res; 2017 Apr; 140():45-54. PubMed ID: 28087313
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Potent Antivirals against Amantadine-Resistant Influenza A Viruses by Targeting the M2-S31N Proton Channel.
Li F; Ma C; Hu Y; Wang Y; Wang J
ACS Infect Dis; 2016 Oct; 2(10):726-733. PubMed ID: 27657178
[TBL] [Abstract][Full Text] [Related]
4. Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus.
Wang J; Wu Y; Ma C; Fiorin G; Wang J; Pinto LH; Lamb RA; Klein ML; Degrado WF
Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1315-20. PubMed ID: 23302696
[TBL] [Abstract][Full Text] [Related]
5. Exploring the size limit of templates for inhibitors of the M2 ion channel of influenza A virus.
Duque MD; Ma C; Torres E; Wang J; Naesens L; Juárez-Jiménez J; Camps P; Luque FJ; DeGrado WF; Lamb RA; Pinto LH; Vázquez S
J Med Chem; 2011 Apr; 54(8):2646-57. PubMed ID: 21466220
[TBL] [Abstract][Full Text] [Related]
6. 3-Azatetracyclo[5.2.1.1(5,8).0(1,5)]undecane derivatives: from wild-type inhibitors of the M2 ion channel of influenza A virus to derivatives with potent activity against the V27A mutant.
Rey-Carrizo M; Torres E; Ma C; Barniol-Xicota M; Wang J; Wu Y; Naesens L; DeGrado WF; Lamb RA; Pinto LH; Vázquez S
J Med Chem; 2013 Nov; 56(22):9265-74. PubMed ID: 24237039
[TBL] [Abstract][Full Text] [Related]
7. The L46P mutant confers a novel allosteric mechanism of resistance toward the influenza A virus M2 S31N proton channel blockers.
Musharrafieh R; Lagarias PI; Ma C; Tan GS; Kolocouris A; Wang J
Mol Pharmacol; 2019 Aug; 96(2):148-157. PubMed ID: 31175183
[TBL] [Abstract][Full Text] [Related]
8. Virtual Screening Identifies Chebulagic Acid as an Inhibitor of the M2(S31N) Viral Ion Channel and Influenza A Virus.
Duncan MC; Onguéné PA; Kihara I; Nebangwa DN; Naidu ME; Williams DE; Balgi AD; Andrae-Marobela K; Roberge M; Andersen RJ; Niikura M; Ntie-Kang F; Tietjen I
Molecules; 2020 Jun; 25(12):. PubMed ID: 32599753
[TBL] [Abstract][Full Text] [Related]
9. Viral M2 ion channel protein: a promising target for anti-influenza drug discovery.
Moorthy NS; Poongavanam V; Pratheepa V
Mini Rev Med Chem; 2014; 14(10):819-30. PubMed ID: 25342196
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological Characterization of the Spectrum of Antiviral Activity and Genetic Barrier to Drug Resistance of M2-S31N Channel Blockers.
Ma C; Zhang J; Wang J
Mol Pharmacol; 2016 Sep; 90(3):188-98. PubMed ID: 27385729
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of pinanamine derivatives as anti-influenza A M2 ion channel inhibitors.
Zhao X; Jie Y; Rosenberg MR; Wan J; Zeng S; Cui W; Xiao Y; Li Z; Tu Z; Casarotto MG; Hu W
Antiviral Res; 2012 Nov; 96(2):91-9. PubMed ID: 22982118
[TBL] [Abstract][Full Text] [Related]
12. A Study of the Activity of Adamantyl Amines against Mutant Influenza A M2 Channels Identified a Polycyclic Cage Amine Triple Blocker, Explored by Molecular Dynamics Simulations and Solid-State NMR.
Stampolaki Μ; Hoffmann A; Tekwani K; Georgiou K; Tzitzoglaki C; Ma C; Becker S; Schmerer P; Döring K; Stylianakis I; Turcu AL; Wang J; Vázquez S; Andreas LB; Schmidtke M; Kolocouris A
ChemMedChem; 2023 Aug; 18(16):e202300182. PubMed ID: 37377066
[TBL] [Abstract][Full Text] [Related]
13. New polycyclic dual inhibitors of the wild type and the V27A mutant M2 channel of the influenza A virus with unexpected binding mode.
Rey-Carrizo M; Gazzarrini S; Llabrés S; Frigolé-Vivas M; Juárez-Jiménez J; Font-Bardia M; Naesens L; Moroni A; Luque FJ; Vázquez S
Eur J Med Chem; 2015; 96():318-29. PubMed ID: 25899336
[TBL] [Abstract][Full Text] [Related]
14. Virtual screening and molecular growth guide the design of inhibitors for the influenza virus drug-resistant mutant M2-V27A/S31N.
Deng C; Wang X; Wang T; Liu W; Yuan X; Huang Y; Cao S
J Biomol Struct Dyn; 2024 Jul; 42(10):5253-5267. PubMed ID: 37424098
[TBL] [Abstract][Full Text] [Related]
15. Design and pharmacological characterization of inhibitors of amantadine-resistant mutants of the M2 ion channel of influenza A virus.
Balannik V; Wang J; Ohigashi Y; Jing X; Magavern E; Lamb RA; Degrado WF; Pinto LH
Biochemistry; 2009 Dec; 48(50):11872-82. PubMed ID: 19905033
[TBL] [Abstract][Full Text] [Related]
16. Molecular dynamics simulation directed rational design of inhibitors targeting drug-resistant mutants of influenza A virus M2.
Wang J; Ma C; Fiorin G; Carnevale V; Wang T; Hu F; Lamb RA; Pinto LH; Hong M; Klein ML; DeGrado WF
J Am Chem Soc; 2011 Aug; 133(32):12834-41. PubMed ID: 21744829
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of the drug-resistant S31N influenza M2 proton channel.
Thomaston JL; DeGrado WF
Protein Sci; 2016 Aug; 25(8):1551-4. PubMed ID: 27082171
[TBL] [Abstract][Full Text] [Related]
18. Discovery of M2 channel blockers targeting the drug-resistant double mutants M2-S31N/L26I and M2-S31N/V27A from the influenza A viruses.
Musharrafieh R; Ma C; Wang J
Eur J Pharm Sci; 2020 Jan; 141():105124. PubMed ID: 31669761
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of Action of Novel Influenza A/M2 Viroporin Inhibitors Derived from Hexamethylene Amiloride.
Jalily PH; Eldstrom J; Miller SC; Kwan DC; Tai SS; Chou D; Niikura M; Tietjen I; Fedida D
Mol Pharmacol; 2016 Aug; 90(2):80-95. PubMed ID: 27193582
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of the influenza A virus M2 proton channel discovered using a high-throughput yeast growth restoration assay.
Balgi AD; Wang J; Cheng DY; Ma C; Pfeifer TA; Shimizu Y; Anderson HJ; Pinto LH; Lamb RA; DeGrado WF; Roberge M
PLoS One; 2013; 8(2):e55271. PubMed ID: 23383318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
